DNA methylation and cancer PM Das, R Singal Journal of clinical oncology 22 (22), 4632-4642, 2004 | 1755 | 2004 |
Chromatin immunoprecipitation assay PM Das, K Ramachandran, J vanWert, R Singal Biotechniques 37 (6), 961-969, 2004 | 285 | 2004 |
Downregulation of miR-342 is associated with tamoxifen resistant breast tumors DM Cittelly, PM Das, NS Spoelstra, SM Edgerton, JK Richer, AD Thor, ... Molecular cancer 9, 1-12, 2010 | 234 | 2010 |
Oncogenic HER2Δ16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors DM Cittelly, PM Das, VA Salvo, JP Fonseca, ME Burow, FE Jones Carcinogenesis 31 (12), 2049-2057, 2010 | 198 | 2010 |
Early detection of ovarian cancer PM Das, RC Bast Jr Biomarkers in medicine 2 (3), 291-303, 2008 | 145 | 2008 |
Methylation mediated silencing of TMS1/ASC gene in prostate cancer PM Das, K Ramachandran, J VanWert, L Ferdinand, G Gopisetty, IM Reis, ... Molecular cancer 5, 1-10, 2006 | 143 | 2006 |
Jumonji/ARID1 B (JARID1B) protein promotes breast tumor cell cycle progression through epigenetic repression of microRNA let-7e D Mitra, PM Das, FC Huynh, FE Jones Journal of Biological Chemistry 286 (47), 40531-40535, 2011 | 114 | 2011 |
The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways DB Badgwell, Z Lu, K Le, F Gao, M Yang, GK Suh, JJ Bao, P Das, ... Oncogene 31 (1), 68-79, 2012 | 101 | 2012 |
Polymorphisms in the DNA methyltransferase 3b gene and prostate cancer risk R Singal, PM Das, M Manoharan, IM Reis, JJ Schlesselman Oncology reports 14 (2), 569-573, 2005 | 83 | 2005 |
Reactivation of epigenetically silenced HER4/ERBB4 results in apoptosis of breast tumor cells PM Das, AD Thor, SM Edgerton, SK Barry, DF Chen, FE Jones Oncogene 29 (37), 5214-5219, 2010 | 70 | 2010 |
Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk R Singal, L Ferdinand, PM Das, IM Reis, JJ Schlesselman International journal of oncology 25 (5), 1465-1471, 2004 | 69 | 2004 |
The transcription factor NeuroD2 coordinates synaptic innervation and cell intrinsic properties to control excitability of cortical pyramidal neurons F Chen, JT Moran, Y Zhang, KM Ates, D Yu, LA Schrader, PM Das, ... The Journal of Physiology 594 (13), 3729-3744, 2016 | 40 | 2016 |
The ERα coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epithelium J Rokicki, PM Das, JM Giltnane, O Wansbury, DL Rimm, BA Howard, ... Molecular cancer 9, 1-5, 2010 | 37 | 2010 |
Identification of a novel FGFRL1 MicroRNA target site polymorphism for bone mineral density in meta-analyses of genome-wide association studies T Niu, N Liu, M Zhao, G Xie, L Zhang, J Li, YF Pei, H Shen, X Fu, H He, ... Human molecular genetics 24 (16), 4710-4727, 2015 | 24 | 2015 |
NDN is an imprinted tumor suppressor gene that is downregulated in ovarian cancers through genetic and epigenetic mechanisms H Yang, P Das, Y Yu, W Mao, Y Wang, K Baggerly, Y Wang, RT Marquez, ... Oncotarget 7 (3), 3018, 2015 | 21 | 2015 |
The ERBB4 intracellular domain (4ICD) regulates NRG1-induced gene expression in hippocampal neurons JG Allison, PM Das, J Ma, FM Inglis, FE Jones Neuroscience research 70 (2), 155-163, 2011 | 21 | 2011 |
Methylation-mediated silencing of genes is not altered by selenium treatment of prostate cancer cells K Ramachandran, L Navarro, E Gordian, PM Das, R Singal Anticancer research 27 (2), 921-925, 2007 | 19 | 2007 |
Melanoma of the soft parts: diagnosis of metastatic and recurrent tumors by aspiration cytology N Kumar, PM Das, S Jain, P Sodhani, S Gupta Diagnostic cytopathology 28 (6), 295-300, 2003 | 10 | 2003 |
Biology of neoplasia M Dean, K Moitra Cancer epidemiology and prevention. Oxford University Press, New York, 2017 | 8 | 2017 |
Ovarian cancer screening ER Keeler, PM Das, RC Bast, KH Lu Early Diagnosis and Treatment of Cancer Series: Ovarian Cancer, 87-107, 2010 | 1 | 2010 |